Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 19, 2019 07:28 ET | Source: CB2 Insights

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

Company strengthens market presence in United Kingdom with licensing of Electronic Data Capture Technology in partnership with UK-based MyAccess ClinicsMyAccess Clinics to use CB2’s software within...
September 03, 2019 21:49 ET | Source: CB2 Insights

CB2 Insights anuncia nombramiento de directora médica en Colombia y penetra al mercado con enfoque en investigación del Cánnabis

La compañía recluta a la prominente doctora colombiana especialista en medicina integrativa y naturopática, Dra. Paola Cubillos, MD, ND para dirigir los programas de investigación del cánnabis...
September 03, 2019 08:20 ET | Source: CB2 Insights

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

Company recruits prominent Colombian naturopathic and integrative medicine physician Dr. Paola Cubillos, MD, ND to lead medical cannabis research programs to advance emerging marketRapid growth in...
August 28, 2019 16:05 ET | Source: CB2 Insights

CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions

TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare...
August 20, 2019 16:35 ET | Source: CB2 Insights

CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019

TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading data-driven company focused on bringing real-world evidence driven from the...
August 01, 2019 08:00 ET | Source: CB2 Insights

CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive

TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
July 31, 2019 08:00 ET | Source: CB2 Insights

CB2 Insights Adds Former Johnson & Johnson Executive as Director

TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
July 18, 2019 07:11 ET | Source: CB2 Insights

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot

NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
July 18, 2019 07:11 ET | Source: CB2 Insights

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot

NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
July 09, 2019 07:30 ET | Source: CB2 Insights

CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...